1. Search Result
Search Result
Results for "

GEN 1029

" in MedChemExpress (MCE) Product Catalog:

1

Inhibitors & Agonists

2

Inhibitory Antibodies

Cat. No. Product Name Target Research Area
  • HY-P99470

    GEN1029

    TNF Receptor Apoptosis Cancer
    Benufutamab (GEN1029) is a death receptor 5 (DR5)-specific agonistic antibody. Benufutamab is a mixture of 2 noncompeting DR5-specific IgG1 antibodies, each with an E430G mutation in the Fc domain. Benufutamab has antitumor effects .
  • HY-P99559

    GEN-1029; HexaBody-DR5/DR5; Hx-DR5-01/05

    Inhibitory Antibodies Cancer
    Tilogotamab (GEN-1029) is an agonistic hexamer formation-enhanced mixture of two antibodies that target two separate epitopes on death receptor type 5 (DR5). Tilogotamab specifically binds to and activates DR5. Tilogotamab can be used for the research of multiple myeloma (MM) .

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: